Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction

American Journal of Cardiology

Volumn 112, Issue 10, 2013, Pages 1551-1556

  Beigel, Roy ^a   Fefer, Paul ^a   Rosenberg, Nurit ^a   Novikov, Ilia ^a   Elian, Dan ^a   Fink, Noam ^a   Segev, Amit ^a   Guetta, Victor ^a   Hod, Hanoch ^a   Matetzky, Shlomi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; CREATINE KINASE; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ADULT; ANTICOAGULATION; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PREMEDICATION; PRIORITY JOURNAL; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE AGGREGATION;

CORONARY ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; PYRIDINES; THIOPHENES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84887024224     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.07.010     Document Type: Article

References (28)

1. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation N Engl J Med 345 2001 494 502
2. S.R. Stenhubl, P.B. Berger, J.T. Mann 3rd, E.T. Fry, A. Delago, C. Wilmer, E.J. Topol CREDO Investigators Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
3. S.R. Steinhubl, P.B. Berger, D.M. Brennan Topol EJ for the CREDO Investigators Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention J Am Coll Cardiol 47 2006 939 943
4. T. Szuk, M. Gyongyosi, N. Homorodi, C. Kritof, I.F. Edes, A. Facsko, N. Pavo, G. Sodeck, C. Strehblow, S. Farhan, G. Maurer, D. Glogar, H. Domanovits, K. Huber, and I. Edes Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort Am Heart J 153 2007 289 295
5. M.S. Sabatine, C.P. Cannon, M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, B.S. Lewis, S.A. Murphy, C.H. McCabe, E. Braunwald Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA 294 2005 1224 1232
6. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMetes, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, and C.W. Yancy 2013 ACCF/AHA guidelines for the management of ST elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 e78 140
7. The Task Force on management of ST-segment elevation myocardial infarction of the European Society of Cardiology (ESC) P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blomstrom-Lundqvist, M.A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Gianuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, A. van't Hof, P. Widimsky, and D. Zahger ESC guidelines for the management of acute myocardial infarction inpatients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
8. J. Dorler, M. Edlinger, H.F. Alber, J. altenberger, W. Benzer, G. Grimm, K. Huber, O. Pachinger, H. Schuchlenz, P. Siostrzonek, G. Zenker, F. Weidinger Austrian Acute PCI Investigators Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Eur Heart J 32 2011 2954 2961
9. E.I. Lev, R. Kornowski, H. Vaknin-Assa, D. Brosh, S. Fuchs, A. Battler, and A. Asali Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction Am J Cardiol 101 2008 435 439
10. P.J. Vlaar, T. Svilaas, K. Damman, B.J. de Smaet, J.G. Tijssen, H.L. Hillege, and F. Zijlstra Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review Circulation 118 2008 1828 1836
11. L. Bonello, U.S. Tantry, R. Marucci, R. Bindt, D.J. Angiolillo, R. Becker, D.L. Bhatt, M. Cattaneo, J.P. Collet, T. Cuisset, C. Gachet, G. Montalescot, L.K. Jennings, D. Kereiakes, D. Sibbing, D. Trenk, J.W. Van Werkum, F. Paganelli, M.J. Price, R. Waksman, P.A. Gurbel Working Group on High On-treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
12. T. Cuisset, C. Frere, J. Quilici, P.E. Morange, L. Nait-Saidi, C. Melot, L. Bail, M. Lambet, M.C. Alessi, and J.L. Bonnet High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes Thromb Haemost 97 2007 282 287
13. C. Frere, T. Cuisset, J. Quilici, L. Camoin, J. Carvajal, P.E. Morange, M. Lambert, I. Juhan-Vague, J.L. Bonnet, and M.C. Alessi ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome Thromb Haemost 98 2007 838 843
14. T. Geisler, H. Langer, M. Wydymus, K. Gohring, C. Zurn, B. Bigalke, K. Stellos, A.E. May, and M. Gawaz Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Eur Heart J 27 2006 2420 2425
15. S. Matetzky, M. Novikov, L. Gruberg, D. Freimark, M. Feinberg, D. Elian, I. Novikov, E. Di Segni, O. Agranat, Y. Har-Zahav, B. Rabinowitz, E. Kaplinsky, and H. Hod The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA J Am Coll Cardiol 34 1999 1932 1938
16. C.M. Gibson, and A. Schomig Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion Circulation 109 2004 3096 3105
17. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Eng J Med 357 2007 2001 2015
18. T. Jernberg, C.D. Payne, K.J. Winters, C. Darstein, J.T. Brandt, J.A. Jakubowski, H. Naganuma, A. Siegbahn, and L. Wallentin Prasugrel achieves greater platelet inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin treated patients with stable coronary artery disease Eur Heart J 27 2006 1166 1173
19. L. Wallentine, C. Varenhorst, S. James, D. Erlinge, O.O. Braun, J.A. Jakubowski, A. Sugidachi, K.J. Winters, and A. Siegbahn Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Eur Heart J 29 2008 21 30
20. A.D. Michelson, A.L. Frelinger 3rd, E. Braunwald, W.E. Downey, D.J. Angiolillo, N.P. Xenopoulos, J.A. Jakubowski, Y. Li, S.A. Murphy, J. Qin, C.H. McCabe, E.M. Antman, S.D. Wiviott TRITON-TIMI 38 Investigators Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial Eur Heart J 30 2009 1753 1763
21. L. Bonello, M. Pansieri, J. Mancini, R. Bonello, L. Maillard, P. Barnay, P. Rossi, O. Ait-Mokhtar, B. Jouve, F. Collet, J.P. Pevre, O. Wittenberg, A. de Labriolle, E. Camilleri, E. Cheneau, E. Cabassome, F. Dignat-George, L. Camoin-Jau, and F. Paganelli High on treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473
22. G. Parodi, R. Valenti, B. Bellandi, A. Migliorini, R. Marcucci, V. Comito, N. Carrabba, A. San tini, G.F. Gensini, R. Abbate, and D. Antoniucci Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study J Am Coll Cardiol 61 2013 1601 1606
23. D. Alexopoulos, K.C. Theodoropoulos, E.F. Stavrou, I. Xanthopoulou, G. Kassimis, G. Tsigkas, A. Damelou, G. Hahalis, and A. Athanassiadou Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction Cardiovasc Drugs Ther 26 2012 393 400
24. T.G. Nuhrenberg, D. Trenk, S. Leggewie, I. Ristau, M. Amann, C. Startz, W. Hochholzer, C.M. Valina, and F.J. Neumann Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study Platelets 2012 Dec 5 epub ahead of print
25. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vicek, H. Losert, H. Domanovits, W. Schreiber, A.N. Laggner, and B. Jilma Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397
26. G. Campo, M. Valgimigli, D. Gemmati, G. Percoco, S. Tognazzo, G. Cicchitelli, L. Catozzi, P. Malagutti, M. Anselmi, C. Vassanelli, G. Scapoli, and R. Ferrari Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study J Am Coll Cardiol 48 2006 2178 2185
27. J.A. de Lemos, and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J Am Coll Cardiol 38 2001 1283 1294
28. R. Schroder Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction Circulation 110 2004 e506 e510